Abstract
The precision of charged particle therapy dose deposition is its main advantage to conventional radiotherapy and its weakness when encountering range uncertainties in clinical practice. We offer a new perspective on treatment verification by introducing a technique to estimate electronic stopping power during the treatment from the measurement of time between particle target entry and prompt gamma detection (TOF-ULET). For the estimation of electronic stopping power, we developed a lightweight analytical model for axial particle motion inside the patient. We used Monte Carlo simulations of a homogenous PMMA phantom as a first test of our method, achieving ~ 6 % estimation errors for 170 MeV and 189 MeV protons. The in-beam estimation of electronic stopping power opens up new opportunities in treatment adaptation between fractions by not only indicating significant deviations from the treatment plan, but also offering a current estimate of the patients' anatomy along the beam path and - using conversion models - the delivered dose.
Originalsprache | Englisch |
---|---|
DOIs | |
Publikationsstatus | Veröffentlicht - 26.01.2024 |
Veranstaltung | 2022 IEEE Nuclear Science Symposium and Medical Imaging Conference - Milan, Italien Dauer: 05.11.2022 → 12.11.2022 |
Tagung, Konferenz, Kongress
Tagung, Konferenz, Kongress | 2022 IEEE Nuclear Science Symposium and Medical Imaging Conference |
---|---|
Kurztitel | NSS/MIC |
Land/Gebiet | Italien |
Ort | Milan |
Zeitraum | 05.11.22 → 12.11.22 |
Strategische Forschungsbereiche und Zentren
- Forschungsschwerpunkt: Biomedizintechnik
DFG-Fachsystematik
- 205-32 Medizinische Physik, Biomedizinische Technik